{"organizations": [], "uuid": "9a668292c800f421ab42d7738a8a41be3cf37ed5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Blueprint-Medicines-Receives-FDA-Authorization-to-Advance-Novel-Drug-Candidate-into-Clinical-Trial-for-Systemic-Mastocytosis-48209-1/", "country": "US", "title": "Blueprint Medicines Receives FDA Authorization to Advance Novel Drug Candidate into Clinical Trial for Systemic Mastocytosis", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Blueprint Medicines Receives FDA Authorization to Advance Novel Drug Candidate into Clinical Trial for Systemic Mastocytosis", "spam_score": 0.0, "site_type": "news", "published": "2015-09-10T16:01:00.000+03:00", "replies_count": 0, "uuid": "9a668292c800f421ab42d7738a8a41be3cf37ed5"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Blueprint-Medicines-Receives-FDA-Authorization-to-Advance-Novel-Drug-Candidate-into-Clinical-Trial-for-Systemic-Mastocytosis-48209-1/", "ord_in_thread": 0, "title": "Blueprint Medicines Receives FDA Authorization to Advance Novel Drug Candidate into Clinical Trial for Systemic Mastocytosis", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": " ", "external_links": [], "published": "2015-09-10T16:01:00.000+03:00", "crawled": "2015-09-10T19:53:29.420+03:00", "highlightTitle": ""}